Chemical modification of arginine and lysine residues in coenzyme-binding domain of carbonyl reductase from rabbit kidney: indomethacin affords a significant protection against inactivation of the enzyme by phenylglyoxal

Biochim Biophys Acta. 1994 Jan 5;1199(1):81-6. doi: 10.1016/0304-4165(94)90100-7.

Abstract

Carbonyl reductase from rabbit kidney was inactivated by phenylglyoxal (PGO) and 2,4,6-trinitrobenzenesulfonate sodium (TNBS). NADP+ protected the enzyme from the inactivations by PGO and TNBS, suggesting that essential arginine and lysine residues are located in coenzyme-binding domain of the enzyme. Judging from the effects of PGO-treated enzymes in the presence and in the absence of NADP+ on the fluorescence intensity of NADPH, one essential arginine residue in coenzyme-binding domain was found to have a role in the binding of NADPH to the enzyme. Indomethacin afforded a significant protection against inactivation of the enzyme by PGO, whereas it could not protect the enzyme from the inactivation by TNBS. It is reasonable to postulate that indomethacin interacts at least in part with or near one essential arginine residue in coenzyme-binding domain of carbonyl reductase from rabbit kidney.

MeSH terms

  • Alcohol Oxidoreductases / antagonists & inhibitors
  • Alcohol Oxidoreductases / chemistry*
  • Alcohol Oxidoreductases / metabolism
  • Animals
  • Arginine / chemistry
  • Enzyme Activation / drug effects
  • Indomethacin / pharmacology*
  • Kidney / drug effects
  • Kidney / enzymology*
  • Lysine / chemistry
  • NADP / metabolism
  • NADP / pharmacology
  • Phenylglyoxal / pharmacology*
  • Rabbits
  • Trinitrobenzenesulfonic Acid / pharmacology

Substances

  • NADP
  • Trinitrobenzenesulfonic Acid
  • Arginine
  • Alcohol Oxidoreductases
  • Lysine
  • Phenylglyoxal
  • Indomethacin